EP4139921A1 - Method and System for Identifying Candidate Immunogenic Protein Regions for Vaccine Development
Summary
The European Patent Office published application EP4139921A1 for NEC OncoImmunity AS, covering a computational method and system for identifying candidate regions of source proteins predicted to instigate an immunogenic response. The invention has applications in vaccine development and creates enforceable patent rights across 36 designated European member states.
What changed
The EPO published European patent application EP4139921A1 for NEC OncoImmunity AS, covering a method and system for identifying candidate regions of source proteins predicted to instigate an immunogenic response, and methods for creating vaccines based on such identification. The application includes IPC classifications in bioinformatics (G16B), pharmaceutical compositions (A61K), and antiviral agents (A61P).
This patent grant creates enforceable intellectual property rights for the applicant across 36 designated European contracting states, including AT, BE, CH, DE, DK, ES, FI, FR, GB, IT, NL, NO, PL, SE, and others. Third parties may seek to oppose the grant within nine months of publication under EPO opposition procedures.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD AND SYSTEM FOR IDENTIFYING ONE OR MORE CANDIDATE REGIONS OF ONE OR MORE SOURCE PROTEINS THAT ARE PREDICTED TO INSTIGATE AN IMMUNOGENIC RESPONSE, AND METHOD FOR CREATING A VACCINE
Publication EP4139921A1 Kind: A1 Apr 08, 2026
Applicants
NEC OncoImmunity AS
Inventors
SIMOVSKI, Boris, MOLINÉ, Clément, STRATFORD, Richard, CLANCY, Trevor
IPC Classifications
G16B 15/30 20190101AFI20211029BHEP A61K 39/00 20060101ALI20211029BHEP G16B 30/00 20190101ALI20211029BHEP A61K 39/12 20060101ALI20211029BHEP A61P 31/14 20060101ALI20211029BHEP C12N 7/00 20060101ALI20211029BHEP G16H 50/50 20180101ALI20211029BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.